India Backs Next-Generation CAR-T Therapy Project to Fight Multiple Myeloma
CAR-T cell therapy is one of the most advanced forms of cancer immunotherapy. In this approach, a patient’s own T cells are collected, genetically modified in the laboratory, and trained to recognise specific markers on cancer cells before being infused back into the patient. Once inside the body, these engineered immune cells can identify and attack cancer cells more precisely. Mayo Clinic describes CAR-T as a therapy in which cells from the body are genetically changed so they can fight cancer, especially blood cancers such as leukaemia, lymphoma and multiple myeloma.